DescriptionUniversity of Colorado | CU Anschutz Medical CampusSchool of Medicine, Department of PathologyPostdoctoral Fellow - Sikora LabPosition #00794731 – Requisition #25036
* Applications are accepted electronically ONLY at www.cu.edu/cu-careers
The University of Colorado has a requirement for COVID-19 vaccinations and full completion thereof by 9/1/21 or upon start date. Information regarding this requirement, and exemptions can be found at:Anschutz: https://www.ucdenver.edu/docs/librariesprovider284/default-document-library/3000-general-admission/3012---covid-19-vaccination-requirement-and-compliance.pdf?sfvrsn=4e9df3ba_2
Exemptions vary by campus location/department. Campus/Unit-Specific Exemptions:
Anschutz Campus – Exemptions are allowed for medical or religious reasons.Denver Campus - Exemptions are allowed for medical, religious, or personal reasons.Consolidated/Central Services Administration – Will follow Anschutz policy on exemptions.
The University of Colorado Anschutz Medical Campus seeks individuals with demonstrated commitment to creating an inclusive learning and working environment. We value the ability to engage effectively with students, faculty and staff of diverse backgrounds.The University of Colorado Anschutz Medical Campus is a world-class medical destination at the forefront of transformative science, medicine, education and patient care. The campus encompasses the University of Colorado health professional schools, more than 60 centers and institutes, and two nationally ranked independent hospitals - UCHealth University of Colorado Hospital
and Children's Hospital Colorado
- that treat more than two million adult and pediatric patients each year. Innovative, interconnected and highly collaborative, the University of Colorado Anschutz Medical Campus delivers life-changing treatments, patient care and professional training and conducts world-renowned research fueled by over $650 million in research grants. For more information, visit www.cuanschutz.edu
Full-time postdoctoral fellow position available for early career scientists with a PhD in Molecular/Cellular Biology, Cancer Biology, Pharmacology, or related fields to join the Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus (Aurora, CO, USA). This position provides the opportunity to join a research team studying hormone signaling in cancers primarily affecting women, with a focus on estrogen receptor pharmacology and anti-estrogen response and resistance.Nature of Work
: The postdoctoral fellow will lead a project studying estrogen-driven tumorigenesis and disease progression in breast cancer. The goal of the project is to use cell culture and in vivo
models to examine how genetic aberrations in breast cancer remodel the estrogen receptor (ER) transcriptome, and how altered ER activity drives cancer development, from tumorigenesis through progression to metastatic disease. The project will utilize in vitro
and in vivo
models of both primary cells and cancer cell lines, standard molecular biology techniques, and genomic profiling methods including RNA-sequencing and CUT&RUN and associated bioinformatics analyses.Professional Field
: Breast cancer, cancer biology, molecular biology, pharmacologySupervision Received
: The postdoctoral fellow will be expected to develop, execute, and interpret studies in an independent manner, with input and mentorship from the principal investigator. Training in this position will support postdoctoral fellows to transition to academic or non-academic careers, as the postdoc will have opportunities to engage in diverse career development opportunities tailored to their needs and interests. Opportunities include:
Funding for annual attendance and presentation at least one national meeting.Mentoring opportunities in the lab with students and summer fellows.The unique ability to work with breast cancer patient/advocate partners in the execution of the project and dissemination of our findings.
Grant writing and fellowship application development programs are available through the laboratory/department and other campus programs. CU Anschutz also has a unique series of career development programs and pathways toward industry, science communication and outreach, science policy, and other career tracks (https://www.cuanschutz.edu/offices/career-development
). The postdoctoral fellow will be encouraged to incorporate these opportunities based on their career goals.Supervision Exercised
: This position will not be associated with formal supervision roles, but the postdoctoral fellow will be expected to collaborate with, train, and mentor other laboratory personnel and trainees.Examples of Work Performed
Mammalian tissue culture and related cell biology assaysStandard molecular biology methods including quantitative PCR, immunoblotting, etc.In vivo tumor xenografting, tumor imaging, and tumor collection/processingGenomic profiling studies and related bioinformaticsMaintain rigorous laboratory records in an electronic lab notebook systemPresent work at local, regional, and national meetingsCommunicate findings with patient/advocate partnersMentor/train other laboratory personnelContribute to laboratory maintenanceSalary and Benefits:
The salary range (or hiring range) has been established at NIH Scale: Career LevelYears of Experience
Stipend for FY 2021Monthly StipendPostdoctoral0$53,760$4,480 1$54,144$4,512 2$54,540$4,545 3$56,712$4,726 4$58,608$4,884 5$60,780$5,065 6$63,036$5,253 7 or More$65,292$5,441The salary of the finalist(s) selected for this role will be set based on a variety of factors, including but not limited to, internal equity, experience, education, specialty and training.The above salary range (or hiring range
) represents the University’s good faith and reasonable estimate of the range of possible compensation at the time of posting.Your total compensation goes beyond the number on your paycheck. The University of Colorado provides generous leave, health plans and retirement contributions that add to your bottom line. Benefits: https://www.cu.edu/employee-services/benefits
Total Compensation Calculator: http://www.cu.edu/node/153125Diversity and Equity:
The University will provide reasonable accommodations to applicants with disabilities throughout the employment application process. To request an accommodation pursuant to the Americans with Disabilities Act, please contact the Human Resources ADA Coordinator at [email protected]
. The University of Colorado Denver | Anschutz Medical Campus is committed to recruiting and supporting a diverse student body, faculty and administrative staff. The university strives to promote a culture of inclusiveness, respect, communication and understanding. We encourage applications from women, ethnic minorities, persons with disabilities, persons within the LGBTQ+ community, and all veterans. The University of Colorado is committed to diversity and equality in education and employment.The University of Colorado Denver | Anschutz Medical Campus is dedicated to ensuring a safe and secure environment for our faculty, staff, students and visitors. To assist in achieving that goal, we conduct background investigations for all prospective employees.
: Applicants must meet minimum qualifications at the time of hire.
- A Ph.D. in a biomedical sciences-related field at the time of initiating the position is required..
- Experience with quantitative PCR, immunoblotting, and related molecular biology methods is required.
- A record of co-authored publications in peer-reviewed journals is required.
- A record of oral and/or poster presentations at national meetings is preferred.
- A record of leadership roles in research and/or community programs is preferred.
- Experience with in vivo tumor modeling is helpful, but not necessary.
- Experience with RNA-sequencing, ChIP-sequencing and related methods, and downstream analyses is helpful, but not necessary.
- Experience with modeling hormone action in breast cancer is helpful, but not necessary.
- Experience with lay audience-focused science communication is helpful, but not necessary.
- Extensive experience with cell/tissue culture using transformed cancer cell lines and/or primary cells is required.
Mar 9, 2022Unposting Date: